Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sara Wahlin"'
Autor:
Sara Wahlin, Karolina Boman, Bruce Moran, Björn Nodin, William M. Gallagher, Emelie Karnevi, Karin Jirström
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background The response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC) is impaired in up to 50% of patients due to chemoresistance, with no predictive biomarkers in clinical use. The proto-oncogene
Externí odkaz:
https://doaj.org/article/23e277afa0164cfbaae39771d287a33d
Autor:
Sofie Olsson Hau, Sara Wahlin, Sophie Cervin, Vilgot Falk, Björn Nodin, Jacob Elebro, Jakob Eberhard, Bruce Moran, William M Gallagher, Emelie Karnevi, Karin Jirström
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 1, Pp 65-77 (2022)
Abstract The outlook for patients with pancreatic cancer remains dismal. Treatment options are limited and chemotherapy remains standard of care, leading to only modest survival benefits. Hence, there is a great need to further explore the mechanisti
Externí odkaz:
https://doaj.org/article/636b8c745cbd42caa4d4e025acbae2fc
Autor:
Nina Andersson, Johan Ohlsson, Sara Wahlin, Björn Nodin, Karolina Boman, Sebastian Lundgren, Karin Jirström
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-12 (2020)
Abstract Background Screening across a multitude of normal and malignant tissues revealed an enhanced expression of lymphocyte antigen 6 superfamily member D (LY6D) in squamous epithelium and urothelium, as well as in malignancies derived therefrom.
Externí odkaz:
https://doaj.org/article/8cd3615ce1694fa59e4244c2099b701c
Publikováno v:
OncoImmunology, Vol 8, Iss 11 (2019)
In patients with muscle invasive bladder cancer (MIBC), neoadjuvant chemotherapy (NAC) prior to radical cystectomy has improved survival but there is an urgent unmet need to identify prognostic and predictive biomarkers to stratify patients who will
Externí odkaz:
https://doaj.org/article/b16096ea4b1c4abb81a7c515efe9a0ef
Autor:
Emelie Karnevi, Sara Wahlin, William M. Gallagher, Sophie Cervin, Bruce Moran, Sofie Olsson Hau, Jakob Eberhard, Vilgot Falk, Jacob Elebro, Karin Jirström, Björn Nodin
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 1, Pp 65-77 (2022)
The Journal of Pathology: Clinical Research
The Journal of Pathology: Clinical Research
The outlook for patients with pancreatic cancer remains dismal. Treatment options are limited and chemotherapy remains standard of care, leading to only modest survival benefits. Hence, there is a great need to further explore the mechanistic basis f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d78c5350aa45a87b0b6dcde3e4ceb965
https://doaj.org/article/636b8c745cbd42caa4d4e025acbae2fc
https://doaj.org/article/636b8c745cbd42caa4d4e025acbae2fc
Autor:
Sara Wahlin, Karolina Boman, Bruce Moran, Björn Nodin, William M. Gallagher, Emelie Karnevi, Karin Jirström
Publikováno v:
BMC Cancer
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
Background The response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC) is impaired in up to 50% of patients due to chemoresistance, with no predictive biomarkers in clinical use. The proto-oncogene RNA-bind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e471df1ae1de7045cf6fb9a5e8ad57e5
https://pubmed.ncbi.nlm.nih.gov/35109796
https://pubmed.ncbi.nlm.nih.gov/35109796
Publikováno v:
Cancer Research. 82:B021-B021
Defined by a high mutational burden and a heterogeneous tissue landscape, muscle-invasive bladder cancer (MIBC) is an aggressive disease with a 5-year mortality rate of approximately 50%. To lower the risk of relapse and improve survival, cisplatin-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4837545b1f7a57607a60371caeaeab51
https://doi.org/10.1158/1538-7445.evodyn22-b021
https://doi.org/10.1158/1538-7445.evodyn22-b021
Autor:
Sara Wahlin, Sebastian Lundgren, Karolina Boman, Johan Ohlsson, Björn Nodin, Nina Andersson, Karin Jirström
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-12 (2020)
Biomarker Research
Biomarker Research
Background Screening across a multitude of normal and malignant tissues revealed an enhanced expression of lymphocyte antigen 6 superfamily member D (LY6D) in squamous epithelium and urothelium, as well as in malignancies derived therefrom. The aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f296bed85bdfff42597353ec94bdfe
https://doi.org/10.1186/s40364-020-00232-1
https://doi.org/10.1186/s40364-020-00232-1
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 8, Iss 11 (2019)
OncoImmunology, Vol 8, Iss 11 (2019)
In patients with muscle invasive bladder cancer (MIBC), neoadjuvant chemotherapy (NAC) prior to radical cystectomy has improved survival but there is an urgent unmet need to identify prognostic and predictive biomarkers to stratify patients who will
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c17ae215ef555c56b6244a476f48de63
http://europepmc.org/articles/PMC6791444
http://europepmc.org/articles/PMC6791444